Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio2.unb.br/jspui/handle/10482/44693
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_SETDomain-ContainingProtein.pdf3,62 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorFaria, Jerusa Araújo Quintão Arantes-
dc.contributor.authorCorrêa, Natássia Caroline Resende-
dc.contributor.authorAndrade, Carolina de-
dc.contributor.authorCampos, Ana Carolina de Angelis-
dc.contributor.authorAlmeida, Rubens dos Santos Samuel de-
dc.contributor.authorRodrigues, Thiago Souza-
dc.contributor.authorGoes, Alfredo Miranda de-
dc.contributor.authorGomes, Dawidson Assis-
dc.contributor.authorPittella-Silva, Fabio-
dc.date.accessioned2022-09-05T15:55:25Z-
dc.date.available2022-09-05T15:55:25Z-
dc.date.issued2013-
dc.identifier.citationFARIA, Jerusa Araújo Quintão Arantes et al. SET domain-containing protein 4 (SETD4) is a newly identified cytosolic and nuclear Lysine Methyltransferase involved in breast cancer cell proliferation. Journal of Cancer Science & Therapy, v. 5, n. 2, p. 59-65, 2013. DOI: 10.4172/1948-5956.1000185. Disponível em: https://www.hilarispublisher.com/open-access/set-domain-containing-protein-4-setd4-is-a-newly-identified-cytosolicand-nuclear-lysine-methyltransferase-involved-in-breast-cancer-cellproliferation-1948-5956.1000185.pdf.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/44693-
dc.language.isoInglêspt_BR
dc.publisherHilarispt_BR
dc.rightsAcesso Abertopt_BR
dc.titleSET domain-containing protein 4 (SETD4) is a newly identified cytosolic and nuclear Lysine Methyltransferase involved in breast cancer cell proliferationpt_BR
dc.typeArtigopt_BR
dc.subject.keywordMamas - câncerpt_BR
dc.subject.keywordProteínaspt_BR
dc.rights.licenseCopyright: © 2013 Arantes Faria JAQ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.pt_BR
dc.identifier.doi10.4172/1948-5956.1000185pt_BR
dc.description.abstract1Cancer is comprised of a multitude of epigenetic abnormalities, including the global loss and regional gain of DNA methylation as well as alterations in histone methylation. Here, we characterize a new methyltransferase, SET domain-containing protein 4 (SETD4), which is involved in breast carcinogenesis. Quantitative real-time PCR (qPCR) showed elevated expression levels of SETD4 in several breast cancer cell lines. SETD4 overexpression was confirmed by western blot analysis suggesting a correlation between high expression of SETD4 and a lack of the estrogen receptor (ER) in breast cancer. In addition, cell fractionation studies and confocal immunofluorescence revealed the nuclear and non-nuclear localization of this new protein. SETD4 knockdown in breast cancer cell lines significantly suppressed their proliferation and delayed the G1/S cell cycle transition without affecting apoptosis. Furthermore, western blot analysis showed that knockdown of SETD4 decreased cyclin D1 expression, revealing the involvement of SETD4 in cell cycle regulation. These data imply that SETD4 plays a crucial role in breast carcinogenesis and could be a novel molecular target for the development of new strategies for the diagnosis and treatment of breast cancer.pt_BR
dc.contributor.affiliationDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais (UFMG)pt_BR
dc.contributor.affiliationDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais (UFMG)pt_BR
dc.contributor.affiliationDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais (UFMG)pt_BR
dc.contributor.affiliationDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais (UFMG)pt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúde, Departamento de Farmáciapt_BR
dc.contributor.affiliationDepartamento de Informática, Centro Federal de Educação Tecnológica de Minas Geraispt_BR
dc.contributor.affiliationDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais (UFMG)pt_BR
dc.contributor.affiliationDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais (UFMG)pt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúde, Departamento de Farmáciapt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.